Evidence map›Paper›PMID 11535638›Full record

ReviewThe Journal of experimental medicine2001

Killing of dendritic cells: a life cut short or a purposeful death?

F Ronchese, I F Hermans

Abstract readCommentReview
In one paragraph

Review in The Journal of experimental medicine, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. T Cell Reprogramming Against Cancer.Methods in molecular biology (Clifton, N.J.) · 2020
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Cutting edge: FcR-like 6 is an MHC class II receptor.Journal of immunology (Baltimore, Md. : 1950) · 2010
    Article
  13. Article
  14. Article
  15. DC-based cancer vaccines.The Journal of clinical investigation · 2007
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

F RoncheseMalaghan Institute of Medical Research, Wellington School of Medicine, 6002 Wellington, New Zealand. fronchese@malaghan.org.nz
I F Hermans

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cytotoxicity, ImmunologicAnimalsCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesDendritic CellsHumansModels, ImmunologicalT-LymphocytesT-Lymphocytes, Cytotoxic

Identifiers

PMID11535638
PMCPMC2195940

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.